$INBX
Inhibrx Biosciences, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is INBX up today? It is at $86.09 (+2.62%), and our scanner flagged it 6 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment INBX spikes, and full due diligence on INBX — key stats, earnings, dilution and insider activity. Free.
Get free $INBX alerts the moment volume spikes
Our scanner flagged $INBX 6 times in the last 30 days. Create a free account to track $INBX, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $86.09
- Change today
- +2.62%
- Previous close
- $83.89
- 52-week range
- $20.55 – $155.29
- Market cap
- $1.23B
- Institutional own.
- 92.50%
- Total held
- 100.0%
- Short interest
- 3.4M ▼ -0% vs prior · as of 2026-07-15
- Days to cover
- 9.0d
- Avg daily volume
- 308K
- Next earnings
- Aug 12 · in 6d
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- XNAS
- 5m
- 1.5x
- 15m
- 1.5x
- 1h
- 0.6x
- 1D
- 0.0x
Get free INBX + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $INBX up today?
Here is the latest on INBX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for INBX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystInhibrx Announces Amended Loan Agreement with Oxford Finance, Expanding Total Facility to $500.0 Million, from the latest SEC filing. Read it →Insiders
7 open-market buys0 buys, 0 sells last 3 months (0/1 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Viking Global Investors Lp Beneficial Owner (10%) | Sold (automatic/other) | -350K 2.4% of company | sold 20% | 1.44M | $11.3M at $32.25 | Oct 7, 25 |
Kayyem Jon Faiz Director | Sold (automatic/other) | -90K 0.6% of company | sold 7.8% | 1.06M | n/a | Mar 27, 25 |
Kayyem Jon Faiz Director | Sold (automatic/other) | -500K 3.4% of company | sold 50% | 509K | n/a | Dec 16, 24 |
Kayyem Jon Faiz Director | Acquired (grant/award) | +500K 3.4% of company | added 77% | 1.15M | n/a | Dec 16, 24 |
Kayyem Jon Faiz Director | Sold (automatic/other) | -52K 0.4% of company | sold 4.3% | 1.15M | n/a | Dec 6, 24 |
Kayyem Jon Faiz Director | Bought (open market) | +38K 0.3% of company | added 37% | 140K | $532K at $14.19 | Nov 20, 24 |
Kayyem Jon Faiz Director | Bought (open market) | +70K 0.5% of company | n/a | 51K | $992K at $14.23 | Nov 19, 24 |
Vuori Kristiina Md Director | Bought (open market) | +7K 0.05% of company | added 48% | 20K | $100K at $15.00 | Oct 3, 24 |
Lappe Mark Officer | Bought (open market) | +13K 0.09% of company | added 1.4% | 925K | $223K at $17.13 | Sep 16, 24 |
Lappe Mark Officer | Bought (open market) | +27K 0.2% of company | added 4.1% | 693K | $406K at $15.05 | Sep 12, 24 |
Vuori Kristiina Md Director | Bought (open market) | +6K 0.04% of company | added 88% | 14K | $97K at $15.07 | Sep 11, 24 |
Lappe Mark Officer | Bought (open market) | +9K 0.06% of company | added 1.0% | 885K | $129K at $15.19 | Sep 10, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
$INBX Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$INBX Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
Stocks similar to INBX
Comparable names in biological products, (no diagnostic substances), closest in size first.
INBX stock FAQ
Why is $INBX up today?
Here is the latest on INBX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for INBX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the INBX stock price today?
INBX last traded at $86.09, up 2.62% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
When does INBX report earnings?
Inhibrx Biosciences, Inc. Common Stock (INBX) is next expected to report earnings on Wednesday, August 12, 2026, about 6 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Where can I see live INBX alerts?
The INBX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged INBX 6 times in the last 30 days.
What exchange is INBX on?
INBX (Inhibrx Biosciences, Inc. Common Stock) trades on XNAS, with a market cap of about $1.23B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Is INBX good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge INBX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.